Suppressive mechanisms in alloantigen-induced T cell responses by unknown
SUPPRESSIVE  MECHANISMS  IN  ALLOANTIGEN-INDUCED  T 
CELL  RESPONSES* 
BY  MARGARET BECKWITH ANn  SUSAN RICH 
From The Department of Microbiology and Immunology, Baylor College of Medicine, 
Houston, Texas 77030 
Alloantigen-induced T  cell proliferation and cytolytic T  cell development in 
the  mixed  lymphocyte response  (MLR)  ~ involves an  interaction of both  aug- 
menting and suppressive  pathways (1-7).  We have previously characterized a 
soluble suppressor factor, designated MLR-TsF, which is produced by alloanti- 
gen-primed,  Ly-2  +  splenic  T  cells  (7)  and  suppresses  the  mixed  lymphocyte 
response in a  genetically restricted manner (4-6).  In initial studies to identify 
possible sites of MLR-TsF activity and define its mechanism of suppression, we 
determined that MLR-TsF exerts a component of its suppressive effect through 
induction of an Ly-l+2  + second-order suppressor T  cell, termed Ts2 (7). Similar 
multicellular suppressive  pathways  involving  several  distinct  Ts  subsets  and 
soluble  inhibitory factors have  been  demonstrated for a  variety of antigenic 
systems (8-12), However, despite the demonstration of  at least three intermediate 
steps in  suppression,  in  most systems the endpoint mechanism of suppression 
remains unclear. 
Attempts to define the  molecular requirements for T  cell clonal expansion 
and terminal differentiation have recently led to identification of growth factors 
essential  to  T  cell  proliferation  and  cytolytic T  cell  development  (13-15). 
Following antigen activation and an interaction with the macrophage produced 
interleukin, IL-1, T  cells release IL-2 which then binds to high affinity receptors 
on activated T cells, thus driving their proliferation (14). This direct and obligate 
relationship between T  cell proliferation and IL-2 suggested that interference 
with the interleukin cascade, during the processes of IL-2 production, receptor 
expression, binding, or utilization, might represent a general immunosuppressive 
mechanism responsible for the final inhibition observed in many of the diverse 
suppressive systems studied (15).  We therefore investigated the possibility that 
inhibition of the  mixed lymphocyte response  might occur through MLR-TsF 
interference with IL-2 production or activity either directly, or as an endpoint 
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process of Ts2-mediated suppression. 
We report  here that the process of MLR-TsF mediated suppression appears 
to be comprised of two distinct activities. The first derives from a  direct MLR- 
TsF interference with IL-2-driven proliferation of responder T  cells and involves 
inhibition of events occurring subsequent to the IL-2 receptor interaction, rather 
than limitation of IL-2 production or decreased expression or binding capacity 
of IL-2 receptors.  This suppressive activity is clearly separable  from the previ- 
ously described second-order suppressor cell induction (7), and in this paper we 
demonstrate that, although IL-2 may be required for Ts2 expansion, suppression 
is not predominantly a result of competition for or decreased production of IL- 
2.  These results imply that the terminal event associated with Ts2 suppression 
of alloantigen-activated  T  cells  may  also  involve  later  events  in  the  IL-2- 
dependent lymphokine cascade. 
Materials and Methods 
Mice.  BALB/c mice  were  obtained from the  Department  of Cell  Biology, Baylor 
College of Medicine. C57BL/6 (B6) mice were purchased from The Jackson Laboratory, 
Bar Harbor, ME. All experiments utilized 6-10-wk old male mice. 
Preparation of Suppressive Supernatants.  Supernatants were prepared as describedpre- 
viously (4). BALB/c mice were immunized in the hind footpads with 30-50  x  10~B6 
spleen  cells.  4  d  later primed  BALB/c spleen cells  were enriched for viable  cells  by 
hypotonic lysis and filtration through cotton-plugged columns, mixed with equal numbers 
of irradiated (1,500 rads) B6 stimulator cells, and cultured for 24 h at a total concentration 
of 20 x  106 cells/ml in supplemented Eagle's minimal essential medium (MEM) containing 
2%  heat-inactivated fetal calf serum  (FCS)  (Gibco  Laboratories,  Grand  Island,  NY). 
Supernatants were harvested and stored at -70°C for no longer than 2 wk before use. 
All suppressive  supernatants used in this study were generated using B6-primed BALB/c 
responders and B6 stimulators, and are designated MLR-TsF. 
IL-2 Production.  Two sources of IL-2 were used. B6-derived EL4 thymoma cells of a 
cloned subline developed by Dr. J.  Farrar  (NIH)  and obtained from  Dr.  E.  Vitetta, 
University of Texas Health Sciences Center (UTHSC), Dallas, TX were resuspended to 
1 X 106/ml in supplemented RPMI-1640 (MA Bioproducts, Walkersville,  MD) containing 
1% FCS and 12.5 ng/ml phorbol myristic acetate (PMA) (Sigma Chemical Co., St. Louis, 
MO).  Supernatants were  harvested after a  24-h  incubation, and  the  IL-2-containing 
fraction was isolated by a 50-85% saturated ammonium sulfate precipitation. The precip- 
itate was dissolved and dialyzed extensively against phosphate-buffered saline (PBS) before 
final dialysis into Hepes-buffered Hanks' balanced salt solution (HBSS) and storage at 
-20°C  (16).  Alternatively, a  lectin-free, Con  A  supernatant  (CAS)  was  prepared  by 
incubating mouse splenocytes in supplemented RPMI-1640 containing 2% FCS and  10 
ug/ml Con A (Sigma Chemical Co.) for 2 h at 37°C in an atmosphere of 5% CO2. The 
cells  were  then  centrifuged, washed,  and  resuspended  in  supplemented  RPMI-1640 
containing  10%  FCS and  incubated  for an additional  20  h  (17).  Supernatants  were 
harvested, filtered, and stored at -20°C until use. EL4 supernatants generally contained 
approximately 50-100  times more activity than the CAS when compared in the HT2 
assay (see below). All experiments were done using both sources of IL-2 with no qualitative 
difference in results. 
Generation of Ts2 Regulator Cells.  Regulator cells were prepared as described previously 
(7). Briefly, 40 X 106 unprimed BALB/c spleen cells were enriched for viable cells, and 
cultured in a total volume of 4.0 ml containing 2.0 mi of supplemented MEM with 10% 
FCS (MEM-10%) and 2.0 ml of control medium (MEM-2%) or suppressive  supernatants. 
The cultures were established in 60-mm petri dishes (Falcon 3002) and incubated at 37 °C 
on a slowly rocking platform in an atmosphere of 10% CO~, 83% N~, and 7% O2. After 
48  h,  cells were harvested, washed three times in HBSS,  irradiated (1,500  rads),  and BECKWITH  AND  RICH  1855 
resuspended to 5 x  108/ml in MEM-10% before addition to the MLR assay. 
MLR Assay.  Mixed lymphocyte responses were established as described previously (4- 
7) with minor modifications. BALB/c responder and irradiated BALB/c or B6 stimulator 
cells were resuspended in MEM-10%, mixed in a 1:1 ratio, and plated in 96-well flatbottom 
microtiter plates in 0.1  ml volume. MLR-TsF was added to cultures containing  1 x  106 
each responders and stimulators per well.  Control and Ts2 regulator cells,  prepared as 
described above, were added to MLR containing 5 x  105 each responder and stimulator 
cells.  In some experiments 50 #1 of an IL-2-containing supernatant was added to MLR 
in conjunction with MLR-TsF or regulator cells, increasing the total volume to 0.25 ml/ 
well. MLR cultures were incubated at 37°C in an atmosphere of 10% CO2, 83% N2, and 
7%  O,~, and  proliferation  was  assessed  by  the  uptake  of [3H]thymidine  (TdR)  (New 
England Nuclear, Boston, MA) added during the last 18-24 h of a 96-h incubation period. 
Data are expressed as mean counts per minute (cpm) of four replicate cultures with the 
standard error of the mean (SEM).  Net cpm (E-C) were calculated by subtracting cpm of 
cultures containing stimulator cells syngeneic to the responder strain (C) from cpm of 
cultures containing allogeneic stimulator cells (E). 
Percent MLR suppression was calculated as follows: 
(E-C) of MLR containing MLR-TsF or 
regulator cells precultured with MLR-TsF 
% MLR suppression =  1 -  (E-C) of MLR containing MEM-2% or 
regulator cells precultured with MEM-2% 
X  100. 
Bulk Mixed Lymphocyte Cultures.  Bulk cultures were established to assess the effect of 
MLR-TsF on expression  and  function  of IL-2 receptors on alloantigen-activated cells. 
Viable BALB/c spleen cells and irradiated B6 spleen cells were resuspended in supple- 
mented MEM to a concentration of 6 ×  106 cells/ml each and cultured with 50% volume 
of MLR-TsF or MEM-2% in 75-cm  2 tissue culture flasks (Co-Star, Cambridge, MA) in 5% 
CO,,,  37°C  environment.  After a  72- or 96-h incubation  period,  cells were harvested, 
layered  over Lympholyte-M (Cedarlane  Laboratories  Limited,  Hornby,  Ontario,  CA) 
density gradient to recover viable responder cells, and tested for the ability to absorb IL- 
2 activity from IL-2-containing supernatants. Yield and viability of cells cultured in the 
presence  or  absence  of  MLR-TsF  did  not  differ  appreciably.  In  some  experiments, 
responder cells harvested from cultures established in control medium were subsequently 
assayed for their proliferative response to IL-2 in the presence of added MLRoTsF. 
Absorption oflL-2--containing Supernatants.  BALB/c splenocytes were activated for 72 
h with B6-irradiated stimulator cells in the presence of either control medium or MLR- 
TsF. After selection for viable cells on a Lympholyte gradient, 50 x  10  6 responder cells 
from each group were incubated for 2 h at 37 C with  1 ml of a  1/25 dilution of an IL- 
2-containing EL4 supernatant. Supernatants were then harvested and assayed for residual 
IL-2 activity as described below. For some experiments, MLR-TsF was incubated with 4 
x  106 HT2 cells/ml for 4 h at 37°C to remove contaminating IL-2. 
Assay for IL-2 Activity.  I L-2-containing supernatants were assayed directly for ability 
to stimulate proliferation of the  IL-2-dependent cell line HT2, originally described by 
Dr. J. Watson, University of California, Irvine, CA (18) and obtained from Drs. Kappler 
and  Marrack,  National Jewish  Hospital and  Research Center,  Denver,  CO.  HT2 cells 
were washed thoroughly, resuspended in supplemented  RPMI-1640, and  5  x  10 ~ cells 
were cultured in the presence of serial, twofold dilutions of the IL-2-containing super- 
natant as previously described (19).  TdR incorporation was determined during the last 4 
h  of a  24-h  culture  period.  Activity is  presented  here  as  cpm  vs.  dilution  of IL-2- 
containing supernatant. 
Results 
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to MLR-TsF associated limitation of available IL-2, we examined the possibility 
that the addition of excess IL-2 to those cultures would abrogate the suppressive 
effect. MLR consisting of BALB/c responders and irradiated B6 stimulator cells 
were established,  various concentrations  of both  MLR-TsF  and the IL-2-con- 
taining EL4 supernatant were added, and proliferation was measured 96 h later. 
The data in Fig.  1 illustrate that at each concentration of EL4 supernatant used, 
the  suppressive  effect  of  MLR-TsF  was  clearly  retained.  Although  at  higher 
levels  of EL4  supernatant  the  overall  proliferative  response  in  the absence  of 
MLR-TsF was diminished,  significant  MLR suppression was still observed with 
each concentration of MLR-TsF added. These results indicate that the suppres- 
sive  capacity  of  MLR-TsF  is  not  confined  to  a  decrease  in  production  or 
availability of active IL-2, and pointed to the possibility of MLR-TsF interference 
with IL-2 binding or utilization. 
Expression of lL-2 Receptors on MLC Cells Activated  in Presence of MLR-TsF.  We 
next addressed the possibility that an altered IL-2 receptor display and/or binding 
capacity was occurring in MLR-TsF-suppressed cultures. Thus, responder cells 
from 72-h bulk BALB/c anti-B6 MLC cultures containing either 50% MLR-TsF 
or control  medium  were  used  to absorb  IL-2  from  an  EL4  supernatant.  The 
remaining IL-2 activity was assayed on the IL-2-dependent T  cell line HT2 (Fig. 
2).  Responder  cells  activated  in  control  MEM-2%  and  those  activated  in  the 
presence of MLR-TsF demonstrated  equivalent absorption capacities,  reducing 
the dilution  of EL4  supernatant required  to obtain  V2 maximum proliferation 
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FIGURE  1.  Exogenous  IL-2 does not abrogate  MLR-TsF-induced  suppression.  Mixed lym- 
X  10  B6 stimulator cells  1 x  10  BALB/c  responder cells and 1  6  phocyte responses containing  6 
were established in the presence of 0, 12.5, 25, and 50% MLR-TsF as indicated on the abscissa. 
EL4 supernatant was added to a  final dilution of 0  (x),  1/400 (A), 1/200 (&),  1/I00 (11), 1/50 
(O), and 1/25 (O), and proliferation was determined at 96 h. BECKWITH AND RICH  1857 
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FICURE 2.  MLC cells activated in the presence of MLR-TsF express receptors for |L-2. Bulk 
mixed lymphocyte responses containing BALB/c  responder cells and B6  stimulators were 
established  as described in  Materials and Methods. Alter 72  b  50  x  10  ~ gTadient-purified 
responder cells  from cultures containing 50%  control medium (0) or MLR-TsF  (O) were 
incubated with a 1/25 dilution of EL4 supernatant for 2 h at 37°C. Cells were removed, and 
residual [L-2 activity in the supernatants as compared to unadsorbed control EL4 supernatant 
(X) was determined using IL-2-del>~ndent HT2 cells as the indicator population. 
from 1/4s8 in  the unadsorbed control to  1/67 and  1/63, respectively. Therefore, 
although the proliferative response to alloantigen was suppressed by >60%  in 
MLR containing MLR-TsF, these results effectively demonstrate that exposure 
of cells  to  MLR-TsF  during  the  process  of alloantigen  activation  does  not 
quantitatively alter the expression or binding capacity of IL-2 receptors. 
MLR-TsF Activity on IL-2-dependent  T  Cell Proliferation.  Since alloantigen ac- 
tivation and resultant expression of functional IL-2 receptors are not diminished 
by MLR-TsF, interference with binding and utilization of IL-2 was next explored 
as a  mechanism of suppressive activity. We therefore investigated the effect of 
MLR-TsF  on  the  IL-2-driven  proliferative response  of alloantigen-activated 
responder T  cells and the IL-2-dependent, BALB/c-derived HT2 cell line, both 
already expressing surface IL-2  receptors.  In  panel A  of Fig.  3,  BALB/c  re- 
sponder cells harvested from 6-d bulk MLC were plated in microcultures with 
serial  dilutions  of EL4  supernatant  and  several concentrations of MLR-TsF. 
Proliferation measured 24-48 h  later revealed significant dose-related suppres- 
sion  in  all  cultures  receiving MLR-TsF  regardless of the  IL-2  concentration. 
Similarly, in panel B of Fig. 3, the suppressive capacity of MLR-TsF was assayed 
on the proliferative response of HT2 cells by titrating both MLR-TsF and EL4 
supernatant into cultures containing 5 x  103 HT2 cells. The overall IL-2-driven 
HT2 proliferative response was substantially inhibited, with maximum levels of 
responsiveness decreasing as the level of MLR-TsF was increased. If MLR-TsF 
was  directly affecting the  IL-2-receptor  interaction,  a  series  of right-shifted 
curves, each attaining control-level responsiveness at high IL-2 concentrations, 
would  be  predicted.  However,  it  is  evident  that  for  both  HT2  and  MLC 
responder cells, control-level plateau responses were never reached in the pres- 
ence of MLR-TsF regardless of the availability of substantial amounts of IL-2 
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FIGURE 3.  MLR-TsF suppression  of  IL-2  receptor-bearing  responder  cells.  A,  2.5  x  105 
BALB/c responder  cells  from  a  6-d  MLC or B,  5  x  l0  s HT2  cells  were  plated  in  96-well 
microtiter  plates  in  the  presence  of  serial  doubling  dilutions  of  the  EL4  supernatant  (as 
indicated  on  the abscissa)and  0 (x),  12.5 (O), 25 (O), or 50% (A) MLR-TsF. [SH]Thymidine 
incorporation  was determined  24 h later.  In A, maximum cpm  were 41,452, 32,639, 23,442, 
21,274 and EL4 dilutions  giving  50% maximum responses  were  1/489,  11701,  1/776, and 1/ 
778  for 0,  12.5,  25, and 50%  MLR-TsF, respectively.  Similarly,  in B, maximum cpm  were 
24,809,  18,765,  16,748,  13,000, and 50% maximum EL4 dilutions  were  112542,  113127,  1/ 
3082, and 1/3581  for 0,  12.5, 25.0 and 50% MLR-TsF, respectively. 
for each curve remained similar (see figure legend, Fig. 3). Taken together, the 
results shown in panels A and B demonstrate that MLR-TsF exerts a potent dose- 
related suppression  of cells already  expressing  receptors  for IL-2,  and suggest 
that MLR-TsF effects are distinct from IL-2-receptor intervention. 
MLR-TsF Activity on IL-2-pulsed HT2 Cells.  The possibility that MLR-TsF was 
interfering with the IL-2-receptor interaction either by direct competition or by 
a mechanism  of steric hindrance was more directly addressed in the experiment 
shown  in  Fig.  4.  HT2  cells  were  preincubated  with  saturating  levels  of IL-2 
under conditions previously shown to result in maximum binding of radiolabeled 
IL-2 (20). These cells were then assayed for response to IL-2 in the presence of 
50%  MLR-TsF.  Responder cells preincubated with IL-2 were subject to MLR- 
TsF-mediated  suppression  equal  in  magnitude  to that of unpulsed  HT2  ceils, 
thus  indicating  an  MLR-TsF-cell  interaction  occurring  independently  of the 
IL-2-receptor  binding  site.  Although  MLR-TsF  binding  to an  IL-2  receptor- 
associated structure (21) is not ruled out, these data, in concert with those of the 
previous experiments,  strongly suggest that the suppressive event occurs subse- 
quent to the IL-2-receptor interaction. 
Effects of Exogenous IL-2 on  Ts2-Mediated Suppression.  MLR-TsF  suppression 
of HT2 cells presented in Figs. 3 and 4 provide evidence for a direct interaction 
with  IL-2-driven  responder  cells that apparently  bypasses  the role of second- BECKWITH AND  RICH  1859 
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FIGURE 4.  Prepulsing  HT2 cells  with IL-2 does  not decrease  MLR-TsF-induced  suppression. 
HT2 cells were washed  three times  with HBSS, incubated  for 1 h at 4°C with  (A, &) or without 
(O, 0) saturating  dilution  of IL-2-containing  EL4 supernatant. These cells were then plated 
at 5 X 10S/well in the presence of serial doubling dilutions  of EL4 supernatant and control 
medium (A, O) or MLR-TsF  (&, O). Proliferation  was determined  24 h later. 
order suppressor  cells in  overall suppressive  activity. To further define these 
separable suppressive activities with regard to regulation by IL-2, we investigated 
the possibility that Ts2-mediated suppression might result from limited produc- 
tion  or  competition  for  free  IL-2  in  MLR,  a  mechanism observed  in  other 
suppressor  cell  systems  (22-24).  Thus,  Ts2  or  control  cells  were  added  as 
regulator cells to BALB/c anti-B6 MLR with several concentrations of an IL-2- 
containing supernatant. The results shown in  Fig.  5  demonstrate a  moderate, 
dose-related decrease in Ts2 suppressive activity with increasing concentrations 
of the IL-2-containing supernatant. This suggested that a  component of Ts2- 
mediated suppression might result from limitation of available IL-2 and could 
be overcome under conditions of excess IL-2.  However, in this experiment as 
well  as  in  those  done  using  EL4  supernatant  as  an  IL-2  source,  significant 
suppression of the proliferative response was always observed in Ts2-containing 
cultures, even in the presence of high levels of exogenous IL-2. Therefore, a 
major portion  of Ts2-mediated suppression  cannot be  explained by  reduced 
endogenous IL-2, although this mechanism does appear to contribute an element 
to the overall Ts2 suppressive effect. In addition, these results do not rule out a 
limitation of IL-2  production occurring in  conjunction with other  inhibitory 
effects. 
Role oflL-2 in Ts2 Generation.  We next examined the possibility that suppres- 
sion attributed to limited IL-2 in the previous figure might reflect consumption 
of IL-2 by second-order suppressor cells during their MLR-TsF-induced acti- 
vation and expansion. MLR-TsF supernatant used in Ts2 induction contain, in 
addition to the suppressive activities, demonstrable IL-2 (M.  Beckwith, unpub- 
lished observation). This is removed by absorption with HT2 cells under condi- 
tions that do  not  interfere with  the overall  MLR suppressive  capacity of the 
supernatants.  In  the  experiments  shown  in  Fig.  6,  Group  A,  Ts2  induction 
cultures  were  established  by  incubating BALB/c spleen  cells  with  MEM-2%, 1860  MECHANISMS  OF  MIXED  LYMPHOCYTE  RESPONSE  SUPPRESSION 
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FICURE 5.  Exogenous IL-2 does not abrogate Ts2-mediated suppression. Unprimed BALB/c 
splenocytes were cultured for 48 h in the presence of 50%  control medium ([]) or MLR-TsF 
(1~). These  cells  were  washed,  irradiated,  and added  as regulator  cells  to  BALB/c  anti-B6 
mixed  lymphocyte  responses  along  with the  indicated dilution  of Con  A  supernatant as a 
source of IL-2.  Data are expressed as E-C values as described in Materials and Methods, and 
numbers in parentheses represent percent inhibition of suppressed vs. control cultures. 
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FIGURE  6.  Adsorption of MLR-TsF with  HT2  cells decreases  Ts2  induction. Group  A-- 
Unprimed BALB/c splenocytes were cultured with 50%  control medium ([]), MLR-TsF ([]), 
or MLR-TsF that had been  preadsorbed with HT2 cells to remove any contaminating IL-2 
(~]). In addition, induction cultures in Group B contained a  1/1,000 dilution of EL4 supernatant 
as a source of IL-2. After a  48-h culture period, cells were irradiated and added to BALB/c 
anti-B6  MLR.  Proliferation, measured at 96  h,  is expressed as E-C  values,  and numbers in 
parentheses represent percent inhibition of suppressed vs. control cultures. 
unads0rbed  MLR-TsF,  or MLR-TsF that had been depleted of IL-2 by pread- 
sorption with HT2  cells.  The cultures in Group B contained,  in addition,  a  1/ 
1,000  dilution  of the  IL-2-containing  EL4  supernatant.  In  Groups  A  and  B, 
MLR receiving  regulator  cells that had been  cultured with unabsorbed  MLR- 
TsF were each suppressed  by 59%.  This suppression  was reduced by >40%  in BECKWITH  AND  R1CH  1861 
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FIGURE 7.  Kinetics of Ts2 suppression and IL-2 production in Ts2-regulated MLR.  MLR 
were established containing 5 ×  105 BALB/c responder cells, 5 ×  105 B6 stimulator cells and 
5 ×  10  "~ regulator cet~ that had been generated in the presence of 50% control medium (X) 
or MLR-TsF (O).  In A, proliferation of the regulated MLR was measured at 24, 48, 72, and 
96 h. The numbers in parentheses represent percent inhibition of Ts2 vs. control cultures. In 
B, supernatants from identical cultures that had not been labeled with [SH]thymidine were 
taken at each time point, and were tested for IL-2 activity by 24-h assay with IL-2-dependent 
HT2 cells. 
MLR receiving regulators that had been generated with IL-2-depleted MLR- 
TsF  (Group  A),  and  was  completely restored when a  low  level  of IL-2  was 
included in the induction cultures (Group B, closed bar). These results indicate 
that maximal Ts2  induction involves a  molecule that both binds to HT2  cells 
and is present in an EL4 supernatant. Since Ts2 induction was never completely 
blocked when using IL-2-depleted MLR-TsF, these data are consistent with a 
synergistic role for more than one lymphokine, including IL-2, in Ts2 induction. 
Alternatively, a specific suppressor cell inducing moiety in the EL4 supernatant 
may contribute to suppressor cell growth. Taken together, the results shown in 
Figs.  5  and  6  demonstrate that  while second-order suppressor  cells primarily 
inhibit alloantigen-induced proliferation by a mechanism other than consumption 
of endogenously produced IL-2,  they may require  IL-2  during the inductive 
process, and therefore competitively remove a fraction of IL-2 from responder 
cell use. 
IL-2 Production  in Ts2-Suppressed MLR.  We next wished to directly assess the 
level of IL-2 produced in cultures undergoing Ts2-mediated suppression.  Ts2 
or control regulator cells were added to fresh BALB/c anti-B6 MLR, and at 24, 
48,  72,  and  96  h  after  culture  initiation,  suppression  was  monitored  by 
[~H]thymidine uptake (Fig. 7 A), and supernatant samples were taken for deter- 
mination of IL-2 content in the HT2 assay (Fig.  7B).  In Fig.  7A,  the 72-hour 
peak response  in  both  the control and Ts2-regulated MLR  demonstrate that 
Ts2-mediated suppression is not simply due to a shift in the kinetics of prolifer- 
ation. The kinetics of suppression also indicate a late-acting effect, with minimum 1862  MECHANISMS  OF  MIXED  LYMPHOCYTE  RESPONSE  SUPPRESSION 
suppression observed at 48 h, increasing to maximum levels by 96 h after culture 
initiation. This suggests, as was observed with MLR-TsF (4), that Ts2-mediated 
suppression  does  not  appear  to  interfere with  early antigen  recognition and 
activation events, but could involve a limitation in subsequent production of IL- 
2  or  utilization  of IL-2  during  the course of the  response,  thus  limiting the 
proliferative response. However, in Fig. 7B, it is quite clear that equivalent levels 
of IL-2  were measured at each time point  in both control and Ts2-regulated 
MLR,  thus directly demonstrating that  IL-2  production  is not limited in  Ts2 
containing MLR. These data support the concept that Ts2-mediated suppression, 
as  observed  for  MLR-TsF,  may  occur  by  inhibition  of proliferative  signals 
manifest at a later point in the interleukin cascade. 
Discussion 
In this report we investigated the possibility that MLR-TsF suppresses ailoan- 
tigen-stimulated T  cell responses by interference with IL-2-mediated regulation 
of T  cell proliferation. The present data demonstrate that one element of MLR- 
TsF-mediated suppression  involves inhibition  of IL-2-driven  proliferation of 
activated responder T  cells. This inhibition does not result from either limited 
availability of IL-2 in the suppressed culture, or decreased" expression of func- 
tional  IL-2  receptors,  but  appears  primarily  to  involve  interference  with  a 
proliferative event occurring subsequent to the IL-2-receptor interaction. Fur- 
thermore, this  direct inhibitory effect is  clearly distinguishable from the Ts2 
inductive capacity of MLR-TsF. In this report we demonstrate that Ts2-mediated 
suppression is comprised of at least two components which together produce a 
late-acting inhibitory effect peaking 72-h after culture initiation. A minor com- 
ponent was overcome by exogenous IL-2,  and may reflect a  requirement for 
I L-2 during Ts2 expansion. However, the most significant element of suppression 
could not be explained by direct competition for IL-2, or by limited production 
of IL-2  in  the  MLR,  and  thus  results  from  a  defect in  later  phases  of the 
proliferative response. 
Since excess levels of exogenous IL-2 failed to abrogate MLR-TsF-mediated 
suppression,  inhibition could not be explained solely by lack of available IL-2. 
This does not rule out the possibility that an MLR-TsF-induced defect in IL-2 
production occurs in conjunction with other inhibitory activities.  Kramer and 
Koszinowski  (25)  describe  a  10,000-dalton  column purified  protein  from  an 
ailoantigen-induced T  cell supernatant that suppresses T  cell responses entirely 
by inhibiting the production of IL-2. However, in our system, attempts to directly 
measure IL-2 production in suppressed cultures was complicated by the inhibi- 
tory effect of MLR-TsF in the HT2 assay used for IL-2 quantitation. Thus, the 
additional possibility that a  decrease in  IL-2 production contributes to overall 
MLR-TsF suppression remains untested. 
Several observations in this report support the concept of MLR-TsF interfer- 
ence with proliferative events occurring subsequent to  IL-2  receptor binding. 
First,  IL-2  absorption  experiments  demonstrated  that  alloantigen-induced 
expression and binding capacity of IL-2  receptors were not limited by MLR- 
TsF. Second, alloantigen-activated T  cells and HT2 cells, both expressing func- 
tional IL-2 receptors, were susceptible to MLR-TsF suppression, and third, this BECKWITH  AND  RICH  1863 
suppression was still observed after presaturation of IL-2 receptors with excess 
IL-2. If these results are examined in the light of models of hormone receptor 
binding proposed for certain types of insulin resistance (26, 27), an interesting 
pattern emerges. Proposed mechanisms of resistance to insulin can be divided 
into prereceptor, receptor, or postreceptor defects. In each case characteristic 
dose-response curves demonstrating either a  decreased sensitivity to insulin, a 
decreased responsiveness, or a combination effect can be utilized to predict which 
mechanism is being observed. Thus, decreased sensitivity to insulin is character- 
ized by  right-shifted  curves,  each  of which  ultimately reaches the maximum 
control level of proliferation at increased hormone concentrations, and would 
be observed in the presence of abnormal insulin molecules or anti-insulin anti- 
bodies. On the other hand, patterns of decreased responsiveness to insulin are 
manifest  by  dose-response  curves  that  never  reach  the  maximum  biological 
response seen in controls, and that require the same concentration of hormone 
to obtain 50% of the maximum response for each curve. For insulin this pattern 
is typically associated with defects in which the abnormal response is localized to 
intracellular events that follow the hormone receptor interaction, and is thus 
classified  as  a  postreceptor  defect  (26-27).  The  profile  of  IL-2-stimulated 
proliferation  observed  in  the  presence  of MLR-TsF  (Figs.  3  and  4)  clearly 
resembles the latter pattern of decreased responsiveness to IL-2. Thus maximal 
proliferation was never obtained in suppressed cultures, and the concentration 
of IL-2 required to yield one-half maximum response was quite similar for each 
curve. This pattern might also be observed if an overall decrease in IL-2 receptors 
was induced by MLR-TsF,  however, this possibility is ruled out by absorption 
experiments  that  indicate  no  MLR-TsF  effect  on  IL-2-receptor  expression. 
Therefore, the observed response is most consistent with a defect occurring after 
the IL-2 receptor interaction, i.e. a postreceptor defect. 
In the increasingly complex cascade of molecular events ultimately resulting 
in T  cell proliferation, initial T  cell activation by mitogen or antigen promotes 
IL-I release by monocytes followed by T  cell production of IL-2 and expression 
of IL-2  receptors.  In  contrast,  those steps  occurring after the  IL-2-receptor 
interaction are less  clear,  and  stimulation of additional  cell-surface molecules 
may be required before DNA synthesis. Receptors for the iron-binding glycopro- 
tein  transferrin  appear  on  activated  human  T  cells only after  IL-2  receptor 
expression and binding, and the transferrin-receptor interaction is required for 
cell proliferation (28). In addition, Malek et al. (21) have described a monoclonal 
antibody that recognizes a guinea pig T  cell surface antigen that is distinct from 
the  IL-2  receptor  but  required  for  IL-2-driven  proliferation,  thus  possibly 
providing a second growth signal following IL-2 binding. MLR-TsF suppression 
may involve interference with a  cell surface molecule similarly associated with 
IL-2-receptor binding, but critical in the lymphokine cascade only after IL-2 
stimulation has occurred. 
Alternatively, the target of inhibition could be intracellular events involved in 
IL-2-receptor internalization, processing in lysosomal vesicles (20) or generation 
of Ca  ++- or cAMP-mediated second signals required for proliferation. Palacios 
and Martinez-Maza (29) reported that interference with Ca  ++ uptake by OKT11 
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production of IL-2 and IL-2  receptor expression.  It is therefore unlikely that 
MLR-TsF acts as a negative signal through interference with early Ca÷+-depend  - 
ent events. Binding assays utilizing radiolabeled IL-2 and MLR-TsF preparations 
in conjunction with anti-receptor antibodies will  more precisely define the site 
of MLR-TsF activity. 
Direct MLR-TsF inhibition of HT2 cell proliferation to IL-2 is consistent with 
a  model of two independent mechanisms of MLR-TsF-mediated suppression, 
comprised of direct MLR-TsF interference with proliferating target cells subse- 
quent to IL-2 binding, and initiation of the Ts2 pathway. Alternatively, MLR- 
TsF suppression  of HT2  cell responsiveness could be due to a  soluble factor 
within the MLR-TsF preparation that is produced by early Ts2 during the MLR- 
Ts in  vitro restimulation period,  thus  supporting  the concept of a  sequential 
rather than simultaneous model for MLR-TsF-induced suppression. Production 
ofa nonspecific inhibitor of DTH has been described that follows the genetically 
restricted interaction of an I-J + suppressor factor with a T acceptor cell, and that 
functions through  inhibition  of IL-2  production  (8,  9).  Kinetics of MLR-Ts2 
suppression would be consistent with release of a molecule inhibiting later events 
in  the proliferative phase of clonal expansion rather than initial activation or 
differentiation to an IL-2 responsive state. However, HT2 assay of supernatants 
from control and Ts2-regulated cultures indicates that if Ts2 cells suppress via a 
late-acting soluble factor, it does not function by decreasing IL-2 production or, 
more importantly, by inhibiting  IL-2-driven proliferation of HT2  cells.  This 
lack of suppressive effect on HT2  cells, as opposed to the inhibition observed 
with MLR-TsF, argues against a single sequential pathway of MLR-TsF suppres- 
sion and instead supports  the existence of distinct suppressive  molecules, one 
acting directly on proliferating cells, and another resulting in Ts2 induction and 
subsequent inhibition. 
The precise mechanism of MLR-Ts2-mediated suppression remains unclear, 
however it appears that more than one process contributes to the overall effect. 
Sy  and  co-workers  (2)  described  two  mechanisms of suppression  leading  to 
decreased hapten-specific CTL responses that could be distinguished by their 
susceptibility to excess IL-2. Competitive consumption of IL-2 by added regulator 
cells has been clearly demonstrated for both alloantigen (22,  23) and Con A- 
activated suppressor T  cells (24).  Similarly, modest reconstitution of Ts2-sup- 
pressed MLR by exogenous IL-2 suggested a degree of Ts2-associated consump- 
tion of IL-2.  This appeared to derive from the utilization of IL-2 during Ts2 
induction and expansion rather than from direct limitation of IL-2 production. 
However,  it  is  clear  that  the  most  significant  component  of Ts2-mediated 
suppression  is  not  susceptible  to  exogenous  IL-2,  and  may therefore involve 
interference with later events dependent on IL-2 utilization. 
In summary, the predominant mechanism of alloantigen-induced T  cell sup- 
pression in the present system occurs by interference with IL-2 utilization in the 
face of largely  unimpaired  IL-2  receptor display  or  IL-2  production.  Direct 
interference with IL-2-driven proliferation by MLR-TsF has been isolated more 
precisely to events that occur only after IL-2-receptor binding, and is strikingly 
consistent with a prediction of induced postreceptor defect of hormone-receptor 
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mediated  directly  by  MLR-TsF  and  indirectly  via  Ts2  induction,  and  their 
individual control by restricting  MHC elements remains to be determined, and 
will  contribute  an  important  dimension  to  the  overall  profile  of ailoantigen- 
induced suppression. 
Summary 
In  this  report  we  examined  the  possibility  that  suppression  of the  mixed 
lymphocyte response by MLR-TsF results from interference with IL-2 regulation 
of T  cell  proliferation.  Two  distinct  processes of inhibition  involving  both  a 
direct effect on IL-2-driven proliferation of responder T  cells, and induction of 
a  second-order suppressor  cell  (Ts2)  were described.  Exogenous  IL-2  did  not 
abrogate  MLR-TsF-induced  suppression,  and  activated  responder  cells  from 
suppressed  cultures  expressed  functional  IL-2  receptors  by  IL-2  adsorption 
analysis.  Thus,  suppression  is not due to lack of available IL-2 or to abnormal 
acquisition of receptors for IL-2 during T  cell activation. In contrast, a profound 
MLR-TsF effect on  IL-2-induced  proliferation  of HT2  cells as well as  MLR- 
activated cells was observed even after presaturation of receptors with excess IL- 
2. These results differentiated the direct responder cell effect of MLR-TsE from 
its Ts2 inductive capacity, and localized the defect in responder cell proliferation 
to  events  occurring  subsequent  to  IL-2  binding.  When  analyzed  in  terms  of 
proposed  models  for  hormone-receptor  interactions,  characteristic  dose-re- 
sponse curves similarly predict a postreceptor defect. 
Examination  of the Ts2 pathway of suppression revealed a  late-acting inhibi- 
tory effect peaking 72 h after MLR initiation.  A  minor part of Ts2 activity was 
susceptible to exogenous IL-2, and may reflect a  requirement  for IL-2 during 
Ts2  expansion.  However,  the  most  significant  component  of Ts2-mediated 
suppression was resistant to excess IL-2, and IL-2 production was normal in Ts2- 
regulated  cultures,  thus ruling  out limitation  of IL-2  for responder  cell use as 
the  major  mechanism  of Ts2  suppression.  The  complete pathway of Ts2  sup- 
pression and its functional relationship to other MLR-TsF inhibitory activities is 
not  yet  fully  understood.  However,  these  results  suggest  that  the  ultimate 
mechanisms of alloantigen-induced  suppression involve late events of the IL-2- 
dependent lymphokine cascade. 
We thank Mrs. Sue Floyd for excellent secretarial  assistance. 
Received for publication  11 August 1983. 
References 
1.  Hardt, C., M. R611inghoff, K. Pfizenmaier,  H. Mosmann, and H. Wagner. 1981. Lyt- 
2+3  + CY-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo. J. 
Exp. Med.  154:262. 
2.  Sy, M. S., S.-H. Lee, M. Tsurufuji, K. L. Rock, B. Benacerraf, and R. Finberg.  1982. 
Two distinct  mechanisms regulate the in vivo generation of cytotoxic T cells. J. Exp. 
Med.  156:918. 
3.  Gautum,  S. C.,  M.  L.  Hilfiker,  and J.  R.  Battisto.  1983.  In  vivo development of 
cytolytic T  lymphocytes  (CTL) to hapten-altered self: MLS-disparate  cells facilitate 
the response by neutralizing  IL-2 inhibitor.J. Immunol.  130:533. 1866  MECHANISMS  OF  MIXED  LYMPHOCYTE  RESPONSE SUPPRESSION 
4.  Rich, S. S., and R. R. Rich.  1975. Regulatory mechanisms in cell-mediated immune 
responses.  II.  A  genetically restricted  suppressor  of mixed  lymphocyte reactions 
released by alloantigen-activated spleen cells. J. Exp. Med. 142:1391. 
5.  Rich, S. S., and R. R. Rich.  1976. Regulatory mechanisms in ceil-mediated immune 
responses. III. I-region control of suppressor cell interaction with responder cells in 
mixed lymphocyte reactions.J. Exp. Med. 143:672. 
6.  Rich,  S.  S.,  C.  S.  David, and  R.  R.  Rich.  1979.  Regulatory  mechanisms in  cell- 
mediated immune responses. VII. Presence of I-C subregion determinants on mixed 
leukocyte reaction suppressor factor.J. Exp. Med. 149:114. 
7.  Beckwith,  M.,  and  S.  S.  Rich.  1982.  Suppressor-target interaction  in  alloantigen 
induced responses: induction of a second cell in the suppressive pathway. J. Immunol. 
128:791. 
8.  Zembala, M.  A., G. L. Asherson, B. M.  B. James, V. E.  Stein, and M.  C. Watkins. 
1982.  Anti-haptene T  suppressor factor acts through an I-J  +,  Ly-l-2  ÷, T  acceptor 
cell that releases a  nonspecific inhibitor of the transfer of contact sensitivity when 
exposed to antigen. J. Immunol.  129:1823. 
9.  Malkovsky, M., G. L. Asherson, B. Stockinger, and M. C. Watkins. 1982. Nonspecific 
inhibitor released by T acceptor cells reduces the production of interleukin-2. Nature 
(Lond. ). 300:652. 
10.  Eardley, D.  D., J.  Hugenberger, L.  McVay-Boudreau, F. W. Shen,  R. K. Gershon, 
and H. Cantor.  1978. Immunoregulatory circuits among T-cell sets. I. T-helper cells 
induce other T-cell sets to exert feedback inhibition. J. Exp. Med. 147:1106. 
11.  Sy,  M.  S.,  M.  H.  Dietz,  R.  N.  Germain,  B.  Benacerraf, and  M.  I. Greene.  1980. 
Antigen and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J  + sup- 
pressor T-cell  factors induce  second-order  suppressor T-cells which  express anti- 
idiotypic receptors. J. Exp. Med. 151 : 1183. 
12.  Germain, R. N., and B. Benacerraf. 1981. Hypothesis. A single major pathway of T- 
lymphocyte interactions in antigen-specific immune suppression. Scand. J. Immunol. 
13:1. 
13.  Wagner, H., and M.  R611inghoff.  1978.  T-T interactions during in vitro cytotoxic 
allograft responses. I. Soluble products from activated Ly-1  + T  cells trigger autono- 
mously antigen primed Ly-2+3  ÷ T  cells to cell proliferation and cytolytic activity. J. 
Exp. Med. 148:1523. 
14.  Smith, K. A., L. B. Lachman,J.J. Oppenheim, and M. F. Favata. 1980. The functional 
relationship of the interleukins. J. Exp. Med. 151:1551. 
15.  Gillis,  S., G. R. Crabtree, and K. A. Smith.  1979. Glucocorticoid-induced inhibition 
of T  cell  growth  factor production.  II. The effect on  the  in  vitro generation  of 
cytolytic T  cells. J. Imrnunol. 123:1632. 
16.  Farrar, J. J.,J.  Fuller-Farrar, P.  L. Simon, M.  L. Hiifiker, B. M. Stadler, and W. L. 
Farrar.  1980.  Thymoma production  of T  cell  growth  factor  (interleukin  2). J. 
Immunol.  125:2555. 
17.  Spiess,  P. J., and  S.  A.  Rosenberg.  1981.  A  simplified method  for production  of 
murine T-cell growth factor free of lectin. J. Immunol. Methods. 42:213. 
18.  Watson,  J.  1979.  Continuous  proliferation  of  murine  antigen-specific  helper  T 
lymphocytes in culture.J. Exp. Med. 150:1510. 
Gillis, S., M. M. Ferm, W. Ou, and K. A. Smith. 1978. T cell growth factor: parameters 
of production and a quantitative microassay for activity. J. Immunol.  120:2027. 
Robb,  R. J.,  A.  Munck,  and  K.  A.  Smith.  1981.  T  cell  growth  factor receptors: 
quantitation, specificity, and biological relevance. J. Exp. Med. 154:1455. 
Malek, T. R., R. J. Robb, and E.  M. Shevach.  1983.  Identification of a  membrane 
antigen that is distinct from the interleukin-2 receptor and that may be required for 
19. 
20. 
21. BECKWITH  AND  RICH  1867 
interleukin-2 driven proliferation. J. lmmunol.  130:747. 
22.  Susskind, B. M., V.J. Merluzzi, R. B. Faanes, M. A. Palladino, and Y. S. Choi. 1983. 
Regulatory mechanisms in cytotoxic T  lymphocyte development. I. A suppressor T 
cell subset that regulates the proliferative stage of CTL development. J.  Immunol. 
130:527. 
23.  Gunther, J.,  W.  Haas,  H.  Von  Boehmer.  1982.  Suppression  of T  cell responses 
through competition for T cell growth factors (interleukin 2). Eur.J. Immunol.  12:247. 
24.  Palacios, R., and G.  M611er. 1981. T  cell growth factor abrogates concanavalin A 
induced suppressor cell function. J. Exp. Med.  153:1360. 
25.  Kramer,  M.,  and  V.  Koszinowski.  1982.  T  cell  specific  suppressor  factors  with 
regulatory influence on interleukin-2 production and function. J. lmmunol.  128:784. 
26.  Olefsky, J.  M.,  and  O.  G.  Kolterman.  1981.  Mechanisms of insulin  resistance  in 
obesity and non-insulin-dependent (Type II) diabetics. Am. J. Med.  70:151. 
27.  Rizza, R. A., L.J. Mandarino, andJ. E. Gerich. 1981. Mechanisms of  insulin resistance 
in man: assessment using the insulin dose-response curve in conjunction with insulin- 
receptor binding. Am. J. Med. 70:169. 
28.  Neckers, L. M., and J. Cossman.  1983. Transferrin receptor induction in mitogen- 
stimulated human T  lymphocytes is required for DNA synthesis and cell division and 
is regulated by interleukin-2. Proc. Natl. Acad. Sci. USA. 80:3494. 
29.  Palacios, R., and O. Martinez-Maza. 1982. Is the E receptor on human T lymphocytes 
a "negative signal receptor"?J, lmmunol.  129:2479. 